• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Wi-Fi at the Nightingale, Virtual GP at Carehomes, and New Technologies Related to COVID-19

Share:

May 13, 2020

A COVID-19 contact tracing app is being trialed by 100 soldiers at the Chamblon army base near Lausanne, Switzerland. The Bluetooth-enabled app logs if users have spent more than 15 minutes within two metres of another user. Then, when one uploads a positive test result for COVID-19, the system and alerts users to the contact. In order to test its efficacy, the volunteers must also exchange a validation card.

In order to protect user-privacy, the results are stored on individual Bluetooth devices rather than a central server. The developers hope this will encourage more people to use the app, which in turn will improve results.The app is set for general release 11 May.

Wi-Fi AT NIGHTINGALE

Insmartcities have set up free Wi-Fi in the temporary Nightingale North-East hospital in Sunderland, UK. Separate to the NHS system, the additional super-fast Wi-Fi is so that COVID-19 patients can maintain contact with their loved ones, keeping morale high and curbing some of the psychological impact of isolation whilst obeying lockdown restrictions. The system was installed in less than two days by engineers who remained socially distanced throughout.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

UK CARE HOMES GIVEN VIRTUAL GP

Care homes across the UK are installing remote diagnosis hubs to support patient care during the pandemic without necessitating a doctor’s visit. The contact-free assessment tool, developed by digital health solutions company Medicspot, enables GPs to provide video consultations whilst using connected devices to take real-time vitals with the assistance of carers. The self-service stations can assess the patients temperature, oxygen levels and heart and lung systems, reducing strain on GP services.

NEW UK REMOTE DIAGNOSIS APP

SDG Group have launched Docdot, a new AI-enabled smartphone app to diagnose, triage and monitor COVID-19 patients remotely. After filling out some short questions, the app uses AI technologies and remote photoplethysmography (rPPG), a light signal processing technology developed by binah.ai, to reads a users vital signs through their smartphone camera. The app is able to record heart rate, HRV, oxygen saturation and respiration, which are all crucial indicators of COVID-19 infection. By enabling these to be tested remotely, the app could limit the spread of the virus.

The data retrieved by the app is also geo-referenced and uploaded to the cloud to enable statistical-epidemiological modelling and contagion forecasting.

SWEDISH DIABETES TECH FOR COVID-19

Innovosens AB’s wearable device to measure vitals for diabetics could be used to identify and monitor COVID-19 patients. SMASH – Sweat Metabolite Analysis for Sports and Skin – measures the blood sugar and lactate levels of the user without piercing the skin. Increased lactate levels are also found in patients suffering from lung infections, a side-effect of severe COVID-19 infection. Innovosens is seeking additional funding to adapt and expand their product and to link it to a monitoring app. The company are also offering free prototypes to hospital and care home staff to help protect those most at-risk.

Read more here

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • IDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery PlatformIDEAYA Biosciences Announces Acquisition of Proprietary INQUIRE™ Chemical Library to Enhance Synthetic Lethality Drug Discovery Platform
  • Ada Lovelace Institute Launches Review Into Digital Vaccine Passports and Health Status AppsAda Lovelace Institute Launches Review Into Digital Vaccine Passports and Health Status Apps
  • Alterity Therapeutics Announces Allowance of New Composition of Matter Patent By the United States Patent and Trademark OfficeAlterity Therapeutics Announces Allowance of New Composition of Matter Patent By the United States Patent and Trademark Office
  • VarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal TrialVarmX Raises €30 Million Series B2 Financing for IND Approval and Preparations for Pivotal Trial
  • Redpin Launches with $15.5 Million Series a to Focus on Pain and EpilepsyRedpin Launches with $15.5 Million Series a to Focus on Pain and Epilepsy
  • Tyto Care Launches TytoHome Nationwide at Best Buy StoresTyto Care Launches TytoHome Nationwide at Best Buy Stores
  • Onegevity and EmbodyBio Announce Collaboration to Explore Brain HealthOnegevity and EmbodyBio Announce Collaboration to Explore Brain Health
  • FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’FTC Action on Health Data Sharing Could Put Digital Health ’On Notice’

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications